Bishnoi Sukhram, Puri Harsh Vardhan, Asaf Belal Bin, Pulle Mohan Venkatesh, Kumar Akhil, Kumar Arvind
Centre for Chest Surgery, Sir Ganga Ram Hospital, New Delhi, India.
Lung India. 2021 Jan-Feb;38(1):18-22. doi: 10.4103/lungindia.lungindia_511_20.
Mucoepidermoid carcinoma (MEC) is a primary salivary gland tumor also arising from nonsalivary gland organs of the body such as submucosal glands of tracheobronchial tree. Surgical resection with negative margins is the treatment of choice. All efforts should be made to preserve as much lung parenchyma as possible, by various bronchoplastic procedures. We present our experience with mucoepidermoid tumors and review their management options including lung preservation techniques and outcome of surgery.
This is a retrospective analysis of prospectively maintained data of 14 patients who underwent surgery for MEC. Their demographic data; clinical presentation; and preoperative, intraoperative, and postoperative details were recorded. All patients underwent contrast-enhanced computed tomography of chest and bronchoscopy as part of workup for diagnosis and to assess the location, size, and extent of tumor; extraluminal component; and status of distal lung parenchyma.
There were eight male and six female patients. The median age at the time of surgery was 28.36 years (range 22-45 years). The procedures performed included right upper lobectomy and right pneumonectomy in one patient each, left main bronchus sleeve resection in six patients, left upper sleeve lobectomy in three patients, and carinal resection and reconstruction of neo carina in three patients. Twelve (85.7%) of our patients underwent lung-preserving surgery. The median hospital stay and chest tube removal duration was 4 and 3 days, respectively. The median tumor size was 1.91 cm (range 1-8 cm). The median follow-up was 24 months (ranging from 6 to 78 months).
Radical surgery to achieve R "0" resection with aggressive emphasis on lung preservation is the mainstay of treatment of MEC. Greater awareness of these tumors is necessary to avoid misdiagnosis and to prevent delaying of potential complete resection of MEC.
黏液表皮样癌(MEC)是一种原发性涎腺肿瘤,也可起源于身体的非涎腺器官,如气管支气管树的黏膜下腺。手术切缘阴性的手术切除是首选治疗方法。应通过各种支气管成形术尽一切努力保留尽可能多的肺实质。我们介绍了我们治疗黏液表皮样瘤的经验,并回顾了其管理选择,包括肺保留技术和手术结果。
这是一项对14例接受黏液表皮样癌手术患者的前瞻性维护数据进行的回顾性分析。记录了他们的人口统计学数据、临床表现以及术前、术中和术后的详细情况。所有患者均接受胸部增强计算机断层扫描和支气管镜检查,作为诊断检查的一部分,以评估肿瘤的位置、大小和范围、腔外成分以及远端肺实质的状况。
有8名男性和6名女性患者。手术时的中位年龄为28.36岁(范围22 - 45岁)。所进行的手术包括1例患者行右上叶切除术和右全肺切除术,6例患者行左主支气管袖状切除术,3例患者行左上袖状叶切除术,3例患者行隆突切除及新隆突重建术。我们的患者中有12例(85.7%)接受了保肺手术。中位住院时间和胸管拔除时间分别为4天和3天。中位肿瘤大小为1.91厘米(范围1 - 8厘米)。中位随访时间为24个月(范围6至78个月)。
以积极强调肺保留来实现R“0”切除的根治性手术是黏液表皮样癌治疗的主要方法。有必要提高对这些肿瘤的认识,以避免误诊并防止黏液表皮样癌潜在的完全切除延迟。